Letters to the Editor
Upadacitinib and ustekinumab combination treatment for a refractory case of spondyloarthritis and Crohn's disease
E. Bianchi1, A.P. Pata2, L. Cantarini3, B. Frediani4, S. Gentileschi5
- Department of Medical Sciences, Surgery and Neurosciences, Rheumatology Unit, Azienda Ospedaliero-Universitaria Senese, University of Siena, Italy.
- Department of Medical Sciences, Surgery and Neurosciences, Rheumatology Unit, Azienda Ospedaliero-Universitaria Senese, University of Siena, Italy.
- Department of Medical Sciences, Surgery and Neurosciences, Rheumatology Unit, Azienda Ospedaliero-Universitaria Senese, University of Siena, Italy.
- Department of Medical Sciences, Surgery and Neurosciences, Rheumatology Unit, Azienda Ospedaliero-Universitaria Senese, University of Siena, Italy.
- Department of Medical Sciences, Surgery and Neurosciences, Rheumatology Unit, Azienda Ospedaliero-Universitaria Senese, University of Siena, Italy. stefano.gentileschi@unisi.it
CER17005
2024 Vol.42, N°3
PI 0766
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 37812461 [PubMed]
Received: 20/07/2023
Accepted : 14/09/2023
In Press: 05/10/2023
Published: 27/03/2024
